No Data
No Data
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
GlaxoSmithKline (GSK.US) has submitted a new indication application for mepolizumab injection for the treatment of COPD in China.
According to GSK's official website and public information, it is speculated that the indication for the marketing application of mepolizumab in China may be chronic obstructive pulmonary disease (COPD).
Fund Update: PRIMECAP MANAGEMENT CO/CA/ Just Disclosed New Holdings
Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch
Tariffs Expected to Bring Pharmaceutical Price Bumps, Shortages -- Market Talk
Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)